CCL17/TARC is expressed during the pathogenesis of allergic diseases such as AD and is selectively expressed in Th2 cells (Furukawa, Nakamura, et al., 2004; Saeki & Tamaki, 2006). Here, CCL17 is linked to allergic disease.